Literature DB >> 22466458

Choroidal thickness in inferior staphyloma associated with posterior serous retinal detachment.

Tetsuya Yamagishi1, Hideki Koizumi, Taizo Yamazaki, Shigeru Kinoshita.   

Abstract

PURPOSE: The purpose of the study was to describe the choroidal findings in eyes with posterior serous retinal detachment associated with inferior staphyloma by enhanced depth imaging optical coherence tomography.
METHODS: The study involved five eyes of five patients with the inferior staphyloma accompanied by posterior serous retinal detachment. In each case, the upper border of the staphyloma was lying across the macula. Enhanced depth imaging spectral domain optical coherence tomography was performed in a vertical-sectional manner through the fovea, and the choroidal thicknesses at the thinnest point, at the fovea, and at 0.5 mm and 1.0 mm superior and inferior to the thinnest point were measured. Fluorescein angiography and indocyanine green angiography were also performed.
RESULTS: In all 5 eyes, the choroid was thinnest at the upper border of the staphyloma (mean, 37.4 μm; SD, 13.5 μm; range, 23-53 μm). Fluorescein angiography showed a band of window defects along the upper border of the staphyloma, where indocyanine green angiography demonstrated persistent hypoperfusion in all 5 eyes.
CONCLUSION: The choroid was markedly thin at the upper border of the inferior staphyloma accompanied by posterior serous retinal detachment. Such choroidal abnormality seemed to play an important role in the development of serous retinal detachment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22466458     DOI: 10.1097/IAE.0b013e318234cae6

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  9 in total

Review 1.  Enhanced depth imaging-OCT of the choroid: a review of the current literature.

Authors:  H Laviers; H Zambarakji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-04       Impact factor: 3.117

2.  Suprachoroidal buckling: technique and indications.

Authors:  Ehab N El Rayes; Ebrahim Elborgy
Journal:  J Ophthalmic Vis Res       Date:  2013-10

3.  Progressive retinal detachment secondary to juxtapapillary microholes in association with type 3 posterior staphylomas.

Authors:  Christiana B Dinah; Daniela Vaideanu-Collins; David Hw Steel
Journal:  Clin Ophthalmol       Date:  2014-06-09

4.  Bilateral Serous Retinal Detachment Associated with Inferior Posterior Staphyloma Treated with Scleral Shortening and Vitrectomy.

Authors:  Akihito Kasai; Naotaka Kanda; Tetsuju Sekiryu
Journal:  Case Rep Ophthalmol       Date:  2016-05-24

5.  Structural profile of dome-shaped macula in degenerative myopia and its association with macular disorders.

Authors:  Geun Woo Lee; Jae Hui Kim; Se Woong Kang; Jaeryung Kim
Journal:  BMC Ophthalmol       Date:  2020-05-24       Impact factor: 2.209

6.  Outcomes of Anti-vascular Endothelial Growth Factor Treatment for Foveal Serous Retinal Detachment Associated with Inferior Staphyloma.

Authors:  Eun Kyoung Lee; Hyeong Gon Yu
Journal:  Korean J Ophthalmol       Date:  2019-06

7.  Three cases of macular hole that occurred in inferior scleral staphyloma associated with tilted disc syndrome: a case series.

Authors:  Hiroshi Mizuno; Hiroyuki Suzuki; Masashi Mimura; Masanori Fukumoto; Takaki Sato; Teruyo Kida; Tsunehiko Ikeda
Journal:  J Med Case Rep       Date:  2022-01-29

8.  Serous Retinal Detachment Associated with Dome-Shaped Macula and Staphyloma Edge in Myopic Patients before and after Treatment with Spironolactone.

Authors:  Álvaro Fernández-Vega Sanz; Carlos Mario Rangel; Eva Villota Deleu; Beatriz Fernández-Vega Sanz; Ronald Mauricio Sánchez-Ávila
Journal:  J Ophthalmol       Date:  2016-01-28       Impact factor: 1.909

9.  Macular irregularities of optical coherence tomographic vertical cross sectional images in school age children.

Authors:  Takehiro Yamashita; Hiroto Terasaki; Ryo Asaoka; Naoya Yoshihara; Naoko Kakiuchi; Taiji Sakamoto
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.